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1  |  INTRODUC TION
The presence of senescent cells has been identified in many physio-
logical and pathological conditions such as during embryonic devel-
opment, cancer, ageing and several age- related diseases (Di Micco 
et al., 2020; He & Sharpless, 2017; Munoz- Espin & Serrano, 2014). 
Senescence is characterized by the activation of a complex and het-
erogeneous cellular phenotype presenting a stable cell cycle arrest. 
In spite of the lack of proliferative potential, senescent cells are highly 
metabolic and present elevated levels of transcription and trans-
lation. Furthermore, senescent cells have a very active secretome 
that has been denominated the senescence- associated secretory 
phenotype (SASP). Thus, intercellular communication between se-
nescent cells and their microenvironment is varied and can be medi-
ated by soluble factors (Coppe et al., 2010). Other less characterized 
means of communication are extracellular vesicles, metabolites and 
ions, in addition to cell- to- cell contact, cell- extracellular matrix in-
teraction and cell fusion and cytoplasmic bridges (Fafian- Labora & 
O'Loghlen, 2020). As these different means by which senescent cells 
communicate with their surroundings is context dependent, there is 
need for a better understanding of the molecular mechanisms and 
downstream pathways implicated.
In the last years, there has been an increasing interest in the role 
that extracellular vesicles (EV) play in the context of senescence, 
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Abstract
Cellular senescence plays an important role in different biological and pathological 
conditions. Senescent cells communicate with their microenvironment through a 
plethora of soluble factors, metalloproteases and extracellular vesicles (EV). Although 
much is known about the role that soluble factors play in senescence, the downstream 
signalling pathways activated by EV in senescence is unknown. To address this, we 
performed a small molecule inhibitor screen and have identified the IκB kinases IKKε, 
IKKα and IKKβ as essential for senescence mediated by EV (evSASP). By using phar-
macological inhibitors of IKKε, IKKα and IKKβ, in addition to CRISPR/Cas9 targeting 
their respective genes, we find these pathways are important in mediating senes-
cence. In addition, we find that senescence activation is dependent on canonical NF- 
κB	transcription	factors	where	siRNA	targeting	p65	prevent	senescence.	Importantly,	
these IKK pathways are also relevant to ageing as knockout of IKKA, IKKB and IKKE 
avoid the activation of senescence. Altogether, these findings open a new potential 
line of investigation in the field of senescence by targeting the negative effects of the 
evSASP independent of particular EV contents.
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ageing and cancer (Fafian- Labora & O'Loghlen, 2020). Many groups 
have identified different individual components enriched in the EV 
SASP (evSASP) such as microRNA (miR) (Jeon et al., 2019; Terlecki- 
Zaniewicz et al., 2018), specific proteins (Basisty et al., 2020; 
Borghesan et al., 2019; Kavanagh et al., 2017; Takasugi et al., 2017) 
or nucleic acids (Takahashi et al., 2017). As with the soluble SASP 
(sSASP), the evSASP has detrimental effects on the microenviron-
ment by inducing paracrine senescence in human primary fibroblasts 
(Borghesan et al., 2019), in proliferative chondrocytes in osteoarthri-
tis (Jeon et al., 2019) or by promoting tumour progression (Takasugi 
et al., 2017). However, EV can also induce tissue repair by ameliorat-
ing senescence and ageing- related tissue dysfunction (Fafian- Labora 
et al., 2020; Yoshida et al., 2019).
In order to identify the molecular mechanisms and downstream 
pathways implicated in senescence mediated by the evSASP inde-
pendent of single EV- components, we performed a small molecule 
inhibitor screen and identified different signalling pathways includ-
ing the NF- κB pathway. NF- κB proteins are implicated in a wide 
range of innate and adaptive immune responses that regulate cellular 
processes including senescence. NF- κB is regulated by phosphoryla-
tion of one of its cytoplasmic inhibitors, IκB, mediated by IκB kinases 
(IKK), allowing NF- κB nuclear translocation and transcriptional acti-
vation (Taniguchi & Karin, 2018). IKKα- IKKβ heterodimer complexes 
regulate the DNA binding proteins implicated in the canonical NF- κB 
pathway,	including	p50-	p65,	while	IKKα-	homodimers	regulate	p52-	
RELB dimers implicated in the alternative NF- κB pathway (Perkins, 
2007; Taniguchi & Karin, 2018). On the other hand, IKKε can contrib-
ute to the regulation of NF- κB but also type I interferon signalling 
(Shen & Hahn, 2011). Here, we find that pharmacological inhibition 
of IKKα, IKKβ and IKKε and knockout of their respective genes 
using CRISPR/Cas9 technology prevent senescence induced by the 
evSASP. We observe that the evSASP activates transcription factors 
mainly implicated in the canonical NF- κB pathway and that this ef-
fect is dependent again on IKKα, IKKβ and IKKε. Furthermore, two 
independent RNAi targeting the NF- κB canonical transcription fac-
tor	p65	prevent	the	evSASP	functionality.	Altogether,	we	show	that	
the evSASP activation of senescence is dependent on IKKα, IKKβ 
and IKKε and on canonical transcription factors binding to NF- κB 
sequence specific oligonucleotides. Altogether, these findings are 
important as they open a new therapeutic line of research to block 
the unfavourable effects of the evSASP independent of individual 
evSASP content.
2  |  RESULTS
2.1  |  Small molecule inhibitor screen identifies 
different signalling pathways mediated by the evSASP
Our laboratory has previously shown that small extracellular vesicles 
(sEV) in contrast to MV (microvesicles or larger vesicles >200 nm) 
are important mediators of intercellular communication between 
senescent and proliferative cells both in vitro and in vivo in the con-
text of ageing and cancer (Borghesan et al., 2019; Fafian- Labora 
& O'Loghlen, 2020; Fafian- Labora et al., 2020). Although we have 
identified different proteins involved in both these contexts, the 
specific downstream signalling pathways are still unknown. To in-
vestigate this, we took advantage of healthy young human primary 
foreskin fibroblasts (HFFF2) expressing a chimeric form of the 
ligand- binding oestrogen receptor (ER) fused to the active oncogene 
mutant H- RASG12V as donor cells (named iRAS cells). The induction 
of senescence was achieved by adding 200 nM 4- hydroxytamoxifen 
(4OHT) for 48 h followed by 72 h withdrawal in iRAS and control 
vector (termed iC) HFFF2 cells (Borghesan et al., 2019; Rapisarda 
et al., 2017). We isolated sEV from iC and iRAS cells by serial ul-
tracentrifugation as performed previously (Borghesan et al., 2019; 
Fafian- Labora et al., 2019; Fafian- Labora et al., 2020; Thery et al., 
2018) and treated recipient proliferating HFFF2 simultaneously with 
these sEV and a variety of pharmacological drugs inhibiting different 
signalling pathways for 6 days (Figure 1a). As we can see in Figure 1b, 
sEV isolated from iRAS treated with DMSO induced a cell cycle ar-
rest measured by quantifying the percentage of cells incorporating 
BrdU. Media supplemented with EV- depleted FBS was used as a 
control (FBS) and no differences were found between this condi-
tion and sEV from iC cells. However, HFFF2 treatment with inhibi-
tors targeting p38MAPK, mTOR (mammalian target of rapamycin) 
F I G U R E  1 Small	molecule	inhibitor	screen	identifies	different	signalling	pathways	mediated	by	the	evSASP	(a)	Details	of	the	experimental	
settings to unveil novel signalling pathways mediated by the evSASP. Senescence was induced in iRAS donor cells by addition of 200 nM 
4- hydroxytamoxifen (+4OHT). HFFF2 recipient cells were treated with a panel of small molecule inhibitors in addition to sEV isolated from 
iC and iRAS cells. Drugs were maintained for 6 days and washed out. (b) Box and Whiskers plot representing the data obtained from the 
screen measuring proliferation by quantifying the percentage of HFFF2 that stain positive for BrdU. The graph indicates the targets of 
the	small	molecule	inhibitors	used:	40	µM	PD98059	(targeting	MEK1/2),	20	µM	SB202190	(p38MAPK),	4	µM	TGFB-	R1	(TGFBR1	kinase),	
8	µM	VEGFR2	(VEGFR2),	150	nM	GSK429286A	(ROCK1/2,	Rho-	associated	kinase),	50	nM	CPD22	(ILK,	integrin-	linked	kinase),	1	µM	CPG	
(MNK1/2), 100 nM TORIN2 (mTOR, mammalian target of rapamycin), 1µM RUXOLITINIB (JAK1/2 inhibitor), 40µM AG- 490 (JAK2/3 kinase), 
45	µM	JANEX1	(JAK3	kinase),	1	µM	AG-	879	(protein	Tyrosine	Kinase),	2	µM	IMATINIB	(tyrosine	kinase;	TK1),	20	µM	CAY10576	(IKKε, IκB 
kinase	epsilon),	1.5	µM	SUNITINIB	(multi	tyrosine	kinase,	multi-	TK).	Data	show	the	min	to	max	Box	and	Whiskers	plot	of	4	independent	
experiments. Dunnett's multiple comparison test analysis was performed to determine statistical significance. p- values are shown. (c) 
Representative	IF	pictures	for	BrdU	staining	in	HFFF2	cells	treated	with	or	without	20	µM	CAY10576	(IKKε inhibitor) and sEV from iC or 
iRAS.	Scale	bar:	50	µm.	(d)	Representative	IF	images	(left	panels)	and	quantification	(right	panels)	of	cells	staining	positive	for	senescence-	
associated beta galactosidase activity (SA- β-	Gal)	in	HFFF2	fibroblasts	treated	with	20	µM	CAY10576	and	sEV	derived	from	iC	or	iRAS	cells.	
Scale	bar	of	IF	pictures:	50	µm.	All	data	represent	the	mean	±	SEM	of	4–	5	independent	experiments.	Data	were	normalized	to	sEV	from	
iRAS sample. One- way ANOVA analysis was performed with multiple comparisons to the sEV iRAS control sample
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and IKKε (IκB kinase epsilon) pathways prevented the proliferation 
arrest induced by sEV as part of the SASP (termed evSASP herein) 
(Figure 1b, c). IKKε is an essential regulator of innate immunity by 
regulating both the interferon and NF- κB signalling pathway (Shen 
& Hahn, 2011). While we have previously identified the importance 
of the interferon pathway by the evSASP (Borghesan et al., 2019), 
the role that IKKε plays is unknown. To confirm the implication of 
the evSASP on the IKKε pathway, we determined additional mark-
ers of senescence and confirmed that IKKε inhibition using 20µM 
CAY10576	 treatment	 for	 6	 days	 also	 reduced	 the	 high	 levels	 of	
senescence- associated β- galactosidase activity (SA- β- Gal), a com-
mon marker of senescence (Gorgoulis et al., 2019), as shown by IF 
pictures (left panel) and its corresponding quantification (graph) lev-
els (Figure 1d). Next, we decided to determine the levels of another 
important hallmark of senescence, the cell cycle inhibitor p16INK4A. 
When looking at the number of cells staining positive for p16INK4A by 
IF, we could also observe a decrease in these cells when treated with 
CAY10576	shown	by	IF	pictures	(above)	and	its	relative	quantifica-
tion (graph below) (Figure S1a). To confirm that the results observed 
were	not	due	to	cytotoxicity	by	CAY10576,	we	determined	whether	
CAY10576	 was	 inducing	 apoptosis	 in	 the	 donor	 cells	 by	 staining	
with Annexin V and quantifying the number of cells staining posi-
tive by FACS (Figure S1b). Donor cells were used for this analysis to 
test pharmacological toxicity in proliferative versus senescent cells. 
Treatment of HFFF2 with 3 µM Cisplatin for 72 h was used as a posi-
tive control. Cytotoxicity was also determined in HFFF2 recipient 
cells	simultaneously	treated	with	sEV	and	CAY10576	by	determining	
total cell number after treatment where no changes between DMSO 
and	 CAY10576	 treatment	 was	 observed	 (Figure	 S1c).	 Altogether,	
these data suggest a role for IKKε in mediating senescence by the 
evSASP.
2.2  |  Pharmacological inhibition of IKKα and IKKβ 
prevents senescence mediated by the evSASP
As IKKε contributes to regulate NF- κB signalling pathway (Shen & 
Hahn, 2011), we next wanted to determine whether two key play-
ers, IKKα and IKKβ, were implicated in senescence mediated by the 
evSASP. For this, we used two commonly studied small molecule 
drugs that inhibit IKKα and IKKβ, respectively (10 µM BAY11- 7082 
and 10 µM MLN120B for 6 days). Experiments were performed as in 
Figure	1a	with	CAY10576.	Staining	of	HFFF2	cells	for	the	apoptotic	
marker Annexin V and quantification by FACS show that none of 
these drugs induced cell toxicity in our system (Figure S2a). As ex-
pected, treatment with both BAY11- 7082 and MLN120B prevented 
the	changes	mediated	by	the	evSASP	(Figure	2).	CAY10576	was	used	
as a control in all experiments. BAY11- 7082 and MLN120B prevented 
the cell cycle arrest mediated by the evSASP measured by quantify-
ing the percentage of cells incorporating BrdU by IF (Figure 2a, b). 
These drugs also induced a decrease in the percentage of cells stain-
ing positive for SA- β- Gal and p16INK4A	(Figure	2a–	c).	The	percentage	
of	 cells	 staining	positive	 for	 nuclear	 p65,	 a	 key	 component	of	 the	
NF- κB pathway, was also lower when HFFF2 cells were treated with 
BAY11- 7082 and MLN120B confirming the efficacy of the inhibitors 
in	preventing	nuclear	p65	accumulation	(Figure	S2b,	c).	An	additional	
p65	 antibody	was	 used	 to	 corroborate	 staining	 specificity	 (Figure	
S2c). Furthermore, to confirm that additional methods for sEV isola-
tion would produce similar results and that sEV internalization was 
taking place, we isolated sEV from HFFF2 cells expressing an ectopic 
mCherry construct for human CD63 by size exclusion chromatog-
raphy (SEC). We next pooled the sEV- enriched fractions (fractions 
3–	7)	(Figure	S2d),	performed	and	additional	ultracentrifugation	(UC)	
step and treated HFFF2 recipient cells as before. Both sEV and pro-
tein content were determined in 12 different fractions (Figure S2d). 
sEV internalization between the different conditions showed slight 
differences that were not statistically significant (Figure S2e, f).
We have previously shown that the evSASP induces DNA dam-
age in recipient cells (Borghesan et al., 2019). Thus, to confirm that 
SEC- isolated sEV activates senescence, we analysed the number of 
cells with DNA damage by staining with phospho- γH2AX and ob-
served that pharmacological inhibition of IKKα, IKKβ and IKKε pre-
vented the DNA damage response induced by the evSASP with sEV 
isolated by SEC (Figure S2g).
2.3  |  Knockout of IKKα, IKKβ and IKKε using 
sgRNA prevents senescence mediated by the evSASP
To further determine the implication of IKKα, IKKβ and IKKε in 
evSASP- mediated senescence, we proceeded to generate a single 
guide RNA (sgRNA) targeting IKKA, IKKB and IKKE, respectively, in 
a lentiviral vector containing a construct encoding for Cas9 and the 
sgRNA. We next transduced HFFF2 cells with 4 sgRNA per gene 
and after selection proceeded to treat these cells with sEV isolated 
from iC and iRAS cells for 6 days and determined different markers 
of senescence by IF (Figure 3a). As shown in Figure 3, knockdown of 
IKKA, IKKB and IKKE by sgRNA (sgIKKA, sgIKKB and sgIKKE) reversed 
the effects of the evSASP confirming the results obtained with the 
different inhibitors in Figure 2. In fact, sgIKKA, sgIKKB and sgIKKE 
partially prevented the cell cycle arrest induced by the evSASP 
(Figure 3b) and reduced the high levels of β- Gal activity (Figure 3c). 
Furthermore, a decrease in the percentage of cells staining posi-
tive for p16INK4A could also be observed upon the expression of 
F I G U R E  2 Pharmacological	inhibition	of	IKKα and IKKβ	prevents	senescence	mediated	by	the	evSASP	(a–	c)	HFFF2	recipient	cells	
were	treated	with	20	µM	CAY10576,	10	µM	MLN120B	or	10	µM	BAY11-	7082	in	addition	to	sEV	isolated	from	iRAS	cells	for	6	days.	The	
percentage of cells staining positive for (a, b) BrdU, SA- β- Gal and (c) p16INK4A was determined. (a) Quantification of the percentage of cells 
staining positive for BrdU and SA- β- Gal and (b) representative pictures. (c) Quantification and pictures for p16INK4A staining by IF. (a, c) Data 
show	the	mean	±	SEM	of	3	independent	experiments.	One-	way	ANOVA	with	multiple	comparisons	with	the	DMSO/sEV	from	iRAS	sample	
was	performed.	Scale	bar:	50	µm
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sgIKKA, sgIKKB and sgIKKE (Figure 3d). The knockdown efficiency 
for all IKKs was confirmed by determining the mRNA levels by qPCR 
analysis using two different housekeeping genes (Figure S3a). The 
percentage	of	cells	presenting	p65	nuclear	staining	confirmed	the	
disruption of NF- κB pathway upon IKKA, IKKB and IKKE knockdown 
(Figure S3b).
2.4  |  Canonical NF- κB pathway is activated 
by the evSASP
To further confirm the implication of NF- κB pathway in mediating 
evSASP senescence and to discern whether the canonical or non- 
canonical pathways are implicated, we next performed a transcrip-
tion factor high throughput assay to quantify binding of NF- κB 
transcription factors to different oligonucleotides containing NF- κB 
consensus binding sites. For this, we isolated nuclear extracts from 
HFFF2 treated with sEV from iC or iRAS cells and all 3 IKK inhibi-
tors	 (20	µM	CAY10576,	10	µM	MLN120B	or	10	µM	BAY11-	7082)	
or expressing sgRNA targeting all 3 IKKs for 72 h. Binding of dif-
ferent	 transcription	 factors	 implicated	 in	 the	 canonical	 (p65,	 p50	
and	c-	Rel)	or	non-	canonical	 (p52	and	RelB)	activation	of	NF-	κB to 
a DNA sequence containing the NF- κB consensus binding site was 
determined by ELISA. As shown in Figure 4, the evSASP induced 
the activation of the canonical NF- κB pathway while no changes 
could be observed in the activation of factors regulating the non- 
canonical	pathways.	Treatment	of	HFFF2	cells	for	8	h	with	5	ng/ml	
lymphotoxin- β was used as a positive control for the activation of 
non- canonical transcription factor- binding activity. In agreement 
with our previous results, pharmacological inhibition of IKKα, IKKβ 
and IKKε (Figure 4a) or the genetic ablation of IKKA, IKKB and IKKE 
by sgRNA expression (Figure 4b) prevented the binding of all canoni-
cal transcription factors. Thus, these data further confirm that the 
canonical NF- κB pathway is implicated in senescence mediated via 
the evSASP which is dependent on IKKα, IKKβ and IKKε although 
the contribution of each IKK is not determined.
2.5  |  siRNA targeting p65 prevents senescence 
mediated by the evSASP
To further confirm an implication of NF- κB mediated by the evS-
ASP, we took advantage of two independent siRNA targeting the ca-
nonical NF- κB	transcription	factor,	p65.	A	non-	targeting	siRNA	was	
used as a control (Scr). Furthermore, we used previously validated 
siRNA targeting two well characterized effectors of senescence: 
TP53	 (sip53)	 and	CDKN2A (sip16) (Borghesan et al., 2019; Fafian- 
Labora	et	al.,	2019;	Rapisarda	et	al.,	2017)	(Figure	S4a).	Here,	50	nM	
siRNA was reverse transfected simultaneously when plating the re-
cipient HFFF2 cells. Media was changed 24 h later and sEV isolated 
from either iC or iRAS donor cells added 48 h later. The experiment 
was stopped 72 h after and several readout measures were taken 
(Figure	5a).	First,	we	determined	proliferation	by	quantifying	BrdU	
incorporation. sEV derived from iRAS cells and transfected with Scr 
induced a cell cycle arrest by preventing the incorporation of BrdU, 
while	sip53	and	sip16	prevented	the	proliferation	arrest	induced	by	
the	evSASP	(Figure	5b).	Two	independent	siRNA	targeting	p65	(§7	
and	§10)	also	prevented	the	proliferation	arrest	mediated	by	evSASP	
(Figure	5b)	concomitant	with	a	decrease	in	the	cell	numbers	stain-
ing	positive	for	nuclear	p65	(Figure	S4b).	Knockdown	efficiency	was	
validated at the RNA level (Figure S4c) and total cell number was 
determined to confirm that the siRNAs used were not inducing cell 
death	(Figure	S4d).	To	further	confirm	an	implication	for	p65	by	the	
evSASP we determined additional markers of senescence. The num-
ber of cells staining positive for p16INK4A mediated by evSASP was 
also	partially	 reduced	by	both	p65	 siRNA	 (§7	and	§10)	 (Figure	5c)	
and	sip53	and	sip16.	Furthermore,	we	could	also	observe	that	down-
regulation	of	p65	siRNA	(§7	and	§10)	also	prevented	the	stabiliza-
tion	of	p53	mediated	by	 the	evSASP	 (Figure	5d).	The	reduction	 in	
the	 protein	 levels	 of	 p53	 and	 p16INK4A using their corresponding 
siRNA,	sip53	and	sip16,	was	confirmed	by	IF	(Figure	5c,	5d).	IL-	8	has	
been shown to induce senescence and its expression is regulated 
by	p65	(Acosta	et	al.,	2008).	We	therefore	determined	the	levels	of	
IL-	8	induced	by	the	evSASP	by	protein	(Figure	5e)	and	mRNA	levels	
(Figure	S4e)	and	the	implication	of	p65.	In	fact,	both	siRNA	targeting	
p65	siRNA	(§7	and	§10)	reduced	the	number	of	cells	staining	positive	
for IL- 8 mediated by the evSASP at the protein level and prevented 
IL8	mRNA	upregulation	(Figure	5e	and	Figure	S4e).	Altogether,	these	
data	suggest	that	the	evSASP	activates	senescence	through	p65.
2.6  |  IKKs are important for evSASP senescence in 
human primary fibroblasts from young and old donors
In order to determine the importance of NF- κB and relevant IKKs 
in ageing, we took advantage of four human primary fibroblasts cell 
cultures isolated from young (~2 years) and four cultures from old 
(~70 years) donors. We have previously shown that fibroblasts from 
old donor express several markers of senescence (Fafian- Labora 
et al., 2020; Rapisarda et al., 2017). All cells were used between 
passages	 2–	3	 after	 arrival	 to	 prevent	 the	 onset	 of	 replicative	 se-
nescence. Next, we pooled the conditioned media of all 4 old cell 
F I G U R E  3 Knockout	of	IKKα, IKKβ and IKKε using sgRNA prevents senescence mediated by the evSASP (a) Representation showing the 
experimental settings where HFFF2 recipient cells expressing or not different sgRNA targeting IKKα (sgIKKA), IKKβ (sgIKKB), or IKKε (sgIKKE) 
were	incubated	with	sEV	from	iC	or	iRAS	for	6	days.	(b–	d)	HFFF2	recipient	cells	transduced	with	sgIKKA, sgIKKB or sgIKKE were treated with 
sEV isolated from iC or iRAS cells for 6 days. The percentage of cells and representative pictures staining positive for (b) BrdU, (c) SA- β- Gal 
(d) and p16INK4A	is	shown.	Data	show	the	mean	±	SEM	of	3	independent	experiments.	One-	way	ANOVA	with	multiple	comparisons	to	the	C/
sEV	from	iRAS	sample	was	performed.	Scale	bar:	50	µm
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F I G U R E  4 The	canonical	NF-	κB 
pathway is activated by the evSASP. 
Nuclear extracts were isolated from 
HFFF2 fibroblasts treated with (a) 
different IKKs inhibitors or (b) sgRNA 
targeting IKK and sEV from iC and 
iRAS	simultaneously	for	3	days.	5	ng/
ml lymphotoxin- β (Lym- β) was used as a 
positive control for 8 h for the activation 
of	the	transcription	factors	p52	and	RelB.	
Binding of canonical NF- κB transcription 
factors,	p65,	p50	and	c-	Rel,	to	an	
immobilized DNA fragment is shown upon 
treatment with sEV from iRAS and lost 
when	treating	with	CAY10576,	MLN120B	
and BAY11- 7082 IKKs inhibitors or in 
cells expressing sgRNA against IKKs 
constructs. No binding or changes upon 
the inhibitors treatments or sgRNA 
expression could be observed with the 
non-	canonical	transcription	factors:	p52	
and	RelB.	All	data	show	the	mean	±	SEM	
of	3–	6	independent	experiments.	One-	
way ANOVA analysis was performed with 
multiple comparisons to the iRAS sEV 
control sample
(a)
(b)
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cultures, isolated their sEV and treated individually four young 
cell cultures expressing an empty vector or the different sgIKKs 
(Figure 6a). We next determined the expression levels of differ-
ent markers of senescence by qPCR. We could observed that the 
treatment of all four young cell cultures for 6 days with sEV from 
old cell cultures induced an increase in the expression levels of dif-
ferent mRNA related to the cell cycle (Figure 6b) and the sSASP 
(Figure 6c). We could also observe that this induction of senescence 
was prevented by sgIKKA, sgIKKB and sgIKKE. The knockdown ef-
ficiency was confirmed by qPCR using two housekeeping genes 
(Figure	S5).	Thus,	these	data	demonstrate	that	IKKα, IKKβ and IKKε 
play an important role in senescence mediated by the evSASP in 
human fibroblasts cultures from old and young individuals high-
lighting its relevance in ageing.
3  |  DISCUSSION
The SASP is one of the main means by which senescent cells commu-
nicate with their microenvironment in physiological and pathological 
conditions (He & Sharpless, 2017; Munoz- Espin & Serrano, 2014). In 
fact, it is known that chronic inflammation or inflammaging causes 
tissue damage in ageing. One hypothesis for this is the accumulation 
of senescent cells and the effect of their associated SASP released 
to the microenvironment (Faget et al., 2019; Lee & Schmitt, 2019). 
While much research focuses on the discovery of novel drugs block-
ing the SASP (termed senomorphic drugs) (Di Micco et al., 2020), 
the off- target effects of these drugs on organelle inter- trafficking 
is understudied. During the maturation of the secretome in senes-
cence, multiple organelles are likely to interact such as lysosomes, 
phagosomes and ER- Golgi trafficking (Vizioli et al., 2020). In fact, 
dissecting the release of the soluble SASP (sSASP) from the evSASP 
proves difficult due to common pathways regulating inter- organelle 
communication in senescence (Cavinato et al., 2020; Dou et al., 
2017; Vizioli et al., 2020). Thus, an alternative approach to prevent 
the detrimental effects of the evSASP could be to prevent its effect 
on the microenvironment and neighbouring cells as described in our 
study, approach which has been successfully used in a model of liver 
regeneration (Bird et al., 2018).
Interestingly, the data presented here could open new therapeu-
tic lines of research in the fields of senescence and ageing, i.e., by 
combining the use of senolytic drugs (that selectively kill senescent 
cells) with drugs preventing the downstream signalling of the SASP 
or even SASP components released upon the death of senescent 
cells. Senolytic drugs would not tackle the SASP already released 
prior to the elimination of senescent cells nor the SASP released 
upon the death of senescent cells. Therefore, blocking the down-
stream and paracrine signalling of the SASP after the use of the se-
nolytics could reinforce the negative effect of senescence on ageing.
It is interesting that our data show dependence of different path-
ways to activate senescence by the evSASP. This could be consid-
ered as a limitation of our study, as theoretically several pathways 
would need to be inhibited to prevent the detrimental effect of the 
evSASP. However, the fact that most pathways identified in this 
study lead to a particular common pathway, NF- κB, is an advantage 
(Mowla et al., 2013). Inhibition of NF- κB would not only act as a se-
nomorphic drug but would also prevent evSASP senescence. NF- κB 
is constitutively activated during senescence and is considered a 
key regulator of the sSASP, where inhibition or knockout of several 
components that modulate NF- κB	signalling,	for	example	p65,	have	
proven to dampen the sSASP (Di Micco et al., 2020; Fafian- Labora 
& O'Loghlen, 2020). In contrast, the non- canonical factors NFKB2 
and RelB have been shown to suppress senescence via the epigene-
tic regulator EZH2 (Iannetti et al., 2014). Although activation of the 
sSASP has been mainly attributed to a persistent and unrepairable 
DNA damage response, other stressors such as p38MAPK and cyto-
plasmic chromatin fragments (CCFs) also activate the sSASP through 
NF- κB (Fafian- Labora & O'Loghlen, 2020). However, the intercon-
nection between the different IKK in senescence are understudied. 
Several RNA- seq studies see an increase in RELA, RELB and NFKB2 
transcripts in senescence (Acosta et al., 2013; Borghesan et al., 
2019;	Herranz	et	al.,	2015;	Storer	et	al.,	2013),	but	few	reports	show	
an increase in IKK mRNA as in this study. However, our results show 
an increase in IKK mRNA using different housekeeping genes with 
no significant differences between their expressions in the various 
experimental conditions, suggesting a transcriptional regulation 
upon treatment with the evSASP. Interestingly, a recent study has 
shown that during the initial activation of senescence, IKKβ is acti-
vated by ATM while in the later stages the sSASP is expressed inde-
pendently of IKKα/β and proteasome degradation of IκB in spite of 
depending on the NF- κB	protein	p65	 (Kolesnichenko	et	al.,	2021).	
Altogether, this suggests that the activation of NF- κB is far more 
complicated than initially thought in the context of senescence and 
both the sSASP and evSASP.
The fact that the evSASP activates the IKKα, IKKβ and IKKε path-
ways could be a reflection of different things. The evSASP could be 
activating a common upstream regulator of the NF- κB pathway such 
as IKKβ,	resulting	in	the	nuclear	translocation	of	p65,	with	a	direct	or	
indirect contribution of IKKα and IKKε. In fact, when manipulating a 
single sEV protein component such as the interferon protein IFITM3, 
theoretically targeting a particular evSASP subpopulation, we only 
see partial amelioration of the senescence phenotype mediated by 
the evSASP (Borghesan et al., 2019) indicating that other factors are 
essential or that other sEV populations can mediate evSASP senes-
cence. The other alternative is that we are isolating a heterogeneous 
sEV population (Tkach & Thery, 2016) where one sEV subpopulation 
could be targeting IKKβ while another sEV subpopulation within the 
same sample could be targeting IKKα/IKKε. Interestingly, in all cases, 
we	see	 induction	of	 senescence	and	activation	of	p65.	This	 is	not	
uncommon as EV has been shown to activate NF- κB via TLR signal-
ling in other contexts resulting in the induction of pro- inflammatory 
cytokines by human monocytic cells (Bretz et al., 2013) or during 
parasite infection (Toda et al., 2020).
Importantly, we see that the evSASP employed using the iRAS 
model of senescence represents what happens using an in vitro 
model of ageing. Thus, the downstream signalling pathways involving 
10 of 16  |     FAFIÁN- LABORA ANd O’LOGHLEN
(a)
(b)
(c)
(e)
(d)
    |  11 of 16FAFIÁN- LABORA ANd O’LOGHLEN
IKKα, IKKβ and IKKε observed by four different primary fibroblasts 
isolated from human donors aged between 67 and 80 years old on 
four	different	 fibroblasts	 isolated	 from	donors	aged	1–	3	years	old	
are conserved between both models. Altogether, these results high-
light the importance of the IKKα, IKKβ and IKKε signalling pathways 
in activating senescence by the evSASP in a model of oncogene se-
nescence and ageing. Furthermore, these results could open new 
lines of research for therapeutically targeting senescence in ageing 
and age- related diseases.
4  |  E XPERIMENTAL PROCEDURES
4.1  |  Cell cultures
HFFF2 human foreskin primary male fibroblasts were obtained from 
the Culture Collections (Public Health England). Young and old pri-
mary human fibroblasts cell cultures were obtained from the Coriell 
Cell	Repository	with	the	following	codes:	Young:	GM05399	(1	year	
old;	male),	GM00969	(2	years	old;	female),	GM05565	(3	years	old;	
male),	GM05758	(1	year	old;	male);	Old:	AG16086	(67	years	old;	fe-
male),	AG06240	(80	years	old;	male),	AG13152	(80	years	old;	male),	
AG13222 (81 years old; male). Details on cell passage are described 
as following:
•	 GM05399-	Young;	Arrived	passage	4	 -	Used	at	passage	7	 in	 the	
experiment
• GM00969- Young; Arrived passage 14 - Used at passage 16 in the 
experiment
•	 GM05565-	Young;	 Arrived	 passage	 7-	 Used	 at	 passage	 9	 in	 the	
experiment
•	 GM05758-	Young;	Arrived	passage	4	-	Used	at	passage	7	in	the	
experiment
•	 AG16086-	 Old;	 Arrived	 passage	 5	 -	 Used	 at	 passage	 7	 in	 the	
experiment
•	 AG06240-	Old;	Arrived	passage	15	 -	Used	 at	 passage	17	 in	 the	
experiment
•	 AG13152-	 Old;	 Arrived	 passage	 5	 -	 Used	 at	 passage	 7	 in	 the	
experiment
•	 AG13222-	 Old;	 Arrived	 passage	 5	 -	 Used	 at	 passage	 7	 in	 the	
experiment
Cells were maintained in high- glucose, pyruvate, Dulbecco's 
modified Eagle's medium with 10% foetal bovine serum and 1% 
antibiotic-	antimycotic	 (A/A)	 solution	 in	 a	 37°C	 incubator	with	 5%	
CO2. iC and iRAS HFFF2 cultures were plated in a 100 mm dish. 
After 24 h, the cells (iC and iRAS) were treated with 200 nM 40HT 
for 48 h in DMEM supplemented with 10% (v/v) FBS and 1% A/A. 
Thereafter,	the	cells	were	washed	and	maintained	with	0.5%	(v/v)	in	
EV- depleted FBS and 1% (v/v) A/A for 3 days to collect the medium 
to isolate sEV.
4.2  |  Small molecule inhibitor screen
HFFF2 recipient cells were treated with several inhibitors at the 
below concentrations simultaneously with sEV in medium supple-
mented with 10% (v/v) EV- depleted FBS and 1% (v/v) A/A for 72 h. 
Treatment with inhibitors and sEV was repeated 72 h later and read-
out was determined after 72 h.
Small molecule inhibitor concentrations used for the screen: 
40	 µM	 PD98059	 (targeting	 MEK1/2;	 ThermoFisher),	 20	 µM	
SB202190 (p38MAPK; Santa Cruz Biotech), 4µ M TGFB- R1 
(TGFBR1 kinase; Calbiochem), 8 µM VEGFR2 (VEGFR2; Calbiochem), 
150	 nM	GSK429286A	 (ROCK1/2,	 Rho-	associated	 kinase;	 Abcam),	
50	nM	CPD22	(ILK,	integrin-	linked	kinase;	Calbiochem),	1	µM	CPG	
(MNK1/2; Calbiochem), 100 nM TORIN2 (mTOR, mammalian target of 
rapamycin; CAYMAN Chemical), 1µM RUXOLITINIB (JAK1/2 inhibi-
tor; CAYMAN Chemical), 40 µM AG- 490 (JAK2/3 kinase; CAYMAN 
Chemical),	 45	 µM	 JANEX1	 (JAK3	 kinase;	 CAYMAN	 Chemical),	
1 µM AG- 879 (protein Tyrosine Kinase; CAYMAN Chemical), 2 µM 
IMATINIB (tyrosine kinase; TK1; CAYMAN Chemical), 20 µM 
CAY10576	 (IKKε, IκB	kinase	episilon;	CAYMAN	Chemical),	1.5	µM	
SUNITINIB (multi tyrosine kinase, multi- TK; CAYMAN Chemical). 
Additional small molecular inhibitors used: 10 µM MLN120B (IKKβ, 
IκB kinase beta; MedChemExpress) and 10 µM BAY11- 7082 (IKKα/β, 
IκB kinase alpha/beta; Sigma- Aldrich). Other pharmacological prod-
ucts: lymphotoxin- β (Sigma Aldrich- T7799) and Cisplatin (PHR1624; 
Sigma- Aldrich).
4.3  |  siRNA reverse transfection
HFFF2	cells	were	reverse	transfected	with	50	nM	siRNAs	on	a	well	
of a 96- well plate. After 24 h, the medium was changed. Two days 
later, the cells were washed and incubated with the sEV in medium 
supplemented with 10% (v/v) EV- depleted FBS and 1% (v/v) A/A for 
72 h. siRNAs used in this study are below:
F I G U R E  5 siRNA	targeting	p65	prevents	senescence	mediated	by	the	evSASP.	(a)	Schematic	representation	for	the	experimental	settings	
(left	panel)	and	timings	(right	panel)	of	the	experiments	performed	in	this	figure.	Reverse	transfection	was	performed	with	50	nM	of	the	
indicated siRNA in the recipient cells. After washing the siRNA out, HFFF2 recipient cells were incubated with sEV isolated from either iC or 
iRAS	for	72	h	and	3	days	later	several	markers	of	senescence	were	determined.	(b)	The	use	of	two	independent	siRNA	targeting	p65	(sip65)	
-	§7	and	§10-	prevents	the	cell	cycle	arrest	characteristic	of	evSASP	senescence.	A	scramble	siRNA	control	(Scr)	was	used	as	a	negative	
control while siRNAs targeting CDKN2A (encoding for p16INK4A) (sip16) or TP53	(sip53)	were	used	as	positive	controls.	(c)	The	percentage	
of cells expressing p16INK4A	protein	levels	and	(d)	stabilizing	p53	protein	was	quantified.	(e)	Representative	IF	images	for	IL-	8	expression	
levels	in	HFFF2	transfected	with	the	indicated	siRNAs	and	treated	with	sEV	isolated	from	either	iC	or	iRAS	HFFF2	cells.	Scale	bar:	50	µm.	
Data	show	the	mean	±	SEM	of	6	independent	experiments.	Statistical	analysis	was	performed	using	One-	way	ANOVA.	All	conditions	were	
compared to sEV from iRAS control
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siRNA: p16 SI02623747 QIAGEN
siRNA:	p53 SI02664403 QIAGEN
siRNA:	p65§7 SI02663094 QIAGEN
siRNA:	p65§10 SI04437062 QIAGEN
4.4  |  Retroviral and lentiviral infections
The generation of stable retroviral and lentiviral expression was car-
ried out following previous studies (Acosta et al., 2008; Borghesan 
et al., 2019; Rapisarda et al., 2017). Briefly, retroviral particles were 
generated by transfecting ER- HRASG12V plasmid and retroviral 
helper plasmids (vsvg and gag- pol) with Polyethylenimine (PEI) in 
HEK293T packaging cells for 48h. Recombinant lentiviral particles 
were generated using the second- generation packaging vectors 
psPAX2 and pMD2.G using PEI in HEK293T. The supernatant was 
then	filtered	with	0.45µm	filters	(Starlab)	and	applied	to	HFFF2	cells	
in the presence of 4 µg/ml polybrene (hexadimethrine bromide; 
Sigma- Aldrich) following threee rounds of infection. Cells were sub-
sequently selected with the appropriate antibiotic resistance either 
0.5	μg/ml puromycin or 300 μg/ml neomycin (Invitrogen).
For	infections	with	the	sgRNA,	a	pool	for	the	4	sgRNA	(5	μg per 
single sgRNA) targeting a single IKK was generated by transfect-
ing equal amounts of DNA and the packaging vectors psPAX2 and 
pMD2.G. Infection was performed as described earlier for lentivirus.
F I G U R E  6 IKKs	are	important	for	
evSASP senescence in human primary 
fibroblasts from young and old donors. 
(a) Schematic representation of the 
experimental settings where 4 human 
fibroblasts cell cultures isolated from 
young, Y, (~2 years) and old, O, (~70 years) 
donors were used. Pooled sEV isolated 
from four old cell cultures were used to 
treat four young cell cultures individually 
expressing and empty vector or sgRNAs 
targeting IKKs. (b, c) Relative mRNA levels 
for (b) the cell cycle regulators CDKN1A 
and CDKN2A or (c) components of the 
sSASP IL8 and IL6 were determined. All 
data	represents	the	mean	±	SEM	of	four	
individual cell cultures. One- way ANOVA 
with Dunnett's multiple comparison 
analysis to control sEV old treated sample 
was performed. Data are normalized 
to the control sEV from the old donors 
sample
(a)
(b)
(c)
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4.5  |  CRISPR sgRNA generation
We used the online guide design tool (http://crispr.mit.edu) to iden-
tify ideal sgRNA sequences. The highest scoring sgRNA guides were 
selected. Primers for the below sequences were ordered and the 
complementary primers annealed at 37°C for 30min, followed by at 
95°C	for	5	min	and	then	ramped	down	to	25°C	at	5°C	degrees	per	
min. The annealed synthetic sgRNA oligonucleotides were cloned 
into	pLentiCRISPR	v2	vector	(Addgene	#52961)	at	BsmBI	restriction	
sites. The sgRNA sequences are as follows:
sgIKKA
1. ACAGACGTTCCCGAAGCCGC
2. GCATGAGAAGATTAAGAAGA
3. AATTGGGACCCTCAGCAGAG
4. GCAATGGAATACTGTTCTGG
sgIKKB
1. GCCGTCTGAAATACACTGAG
2. AGTGCGGCAGAAGAGTGAGG
3. GCCGAAGCTCCAGTAGTCGA
4. ACTGCACGGGCTGCCAGTTG
sgIKKE
1. GAGGTACTCCTGGTGTCGGG
2. TGCATCGCGACATCAAGCCG
3. ACAGCACATCGCCCACACGA
4. TGGCCGGCATGAACCACCTG
4.6  |  sEV isolation and treatment
To isolate the sEV fraction, the protocol of differential ultracentrif-
ugation (Thery et al., 2018) was modified and adapted (Borghesan 
et al., 2019; Fafian- Labora et al., 2020). Briefly, 1 × 106 early passage 
donor cells were plated in a 10 cm dish (10 ml media) for each individ-
ual experiment in high glucose Dulbecco´s modified Eagle´s medium 
with 10% (v/v) EV- depleted foetal bovine serum (FBS) and 1% (v/v) 
antibiotic- antimycotic solution (A/A). 72 h prior to sEV collection 
media	was	switched	to	0.5%	EV-	depleted	FBS	except	for	the	young	
and old human primary fibroblasts cell cultures that were kept ii 10% 
EV- depleted FBS. The Conditioned Media was then collected by pi-
petting	from	the	10cm	dish	in	50	mL	falcon	tubes,	centrifuged	at	low	
speed (2,000 g	for	20	min;	k-	factor	of	the	rotor	is	41056)	to	eliminate	
dead cells and cellular debris. This was followed by a 10,000 g cen-
trifugation step for 1 h. The supernatant was then filtered through a 
0.22 µm filter and we further proceeded to the final 100,000 g cen-
trifugation step for 1 h and 20 min. The 100,000 g pellet (sEV) was 
washed	once	in	15	ml	of	PBS	and	resuspended	in	10%	EV-	depleted	
FBS media for the functional cell culture experiments. In summary, 
we resuspend the final 100,000 g pellet in 840 µl EV- depleted media 
and	treated	12	wells	of	a	96-	well	plate	(plated	with	1,500	recipient	
cells each) with 70 µl of the sEV resuspension. Thus, with 10 ml of 
conditioned media from one 10cm dish (1x106 cells) from either iC 
or iRAS cells we treated 12 wells of a 96 well plate. Media with EV- 
depleted serum (FBS10%) was used as negative control in most ex-
periments. Although iRAS cells release more sEV than iC cells, we 
previously validated that the induction of paracrine senescence was 
due to sEV content rather than sEV number (Borghesan et al., 2019). 
A	Sorvall	100SE	Ultra	Centrifuge,	with	a	Beckmann	Fixed	Angle	T865	
rotor was used for sEV isolations. The k- factor of the rotor is 2,08.
4.7  |  Size exclusion chromatography sEV isolation
For size exclusion chromatography (SEC), we used qEV columns (Izon 
Science). Twelve eluted fractions were collected in sequential frac-
tions of 1ml according to the manufacturer's instructions. The parti-
cle and protein concentration of each fraction was then measured by 
NTA and MicroBCA. The fractions enriched in particles and lacking 
protein contaminants were pooled, centrifuged at 100,000 g for 1 h 
20 min and used for functional assays.
4.8  |  Transcription factor binding assay NF- κB
The protocol was performed following the manufacturers instruc-
tions' for the NF- κB Transcription Assay Kit (Colorimetric) (ab207216, 
Abcam). Firstly, the nuclear extraction was achieved using the nuclear 
lysis buffer. Nuclear extracts were incubated with oligonucleotides 
containing NF- κB consensus binding sites for 1 h at room tempera-
ture with mild agitation. After washing with 1 × wash buffer, they 
were incubated with primary antibodies implicated in the canonical 
and non- canonical NF- κB pathway (1:1000) for 1 h at room tempera-
ture. After washing again with 1 × wash buffer, the samples were in-
cubated with HRP- conjugated secondary antibody (1:1000) for 1 h at 
room temperature and washed. The developing solution was added 
to the samples until a colorimetric reaction could be observed after 
which the Stop Solution was added. The absorbance was measured at 
OD	450	nm	using	Synergy	HT	Multi-	Mode	Microplate	Reader.
4.9  |  FACS for Annexin V staining
Apoptosis assay was quantified using the Annexin V, Alexa Fluor™ 
488 conjugate (ThermoFisher Scientific, Cat. No. A23204). Briefly, 
cell medium and cells were collected in a FACS tubes. The cells were 
incubated	with	Annexin	V-	488	(25	µg/ml)	prepared	in	1X	Annexin	
Binding Buffer (ThermoFisher, Cat. No. PNN1001) for 10 min in the 
darkness at room temperature. Thereafter 1 µg/ml PI staining solu-
tion was added and FACS was carried out using the NovoExpress 
Software (Acea, Bio). The flow cytometer used for Annexin V detec-
tion is the ACEA Novocyte (Agilent).
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4.10  |  qPCR analysis
RNA was isolated using TRIzol Reagent (Thermo Fisher) from 
the cells washed with PBS. cDNA was generated using the High- 
Capacity cDNA Reverse Transcription Kit (ThermoFisher) according 
the manufacturer´s instructions. qPCR was performed using SYBR 
Green	PCR	Master	Mix	(Applied	Biosystems)	on	a	7500	Fast	System	
RealTime PCR cycler (Applied Biosystems). Primers sequences used 
in this study are:
• RPS14: For CTGCGAGTGCTGTCAGAGG; Rev TCACCGCCCTAC 
ACATCAAACT
• ACTB: For GCCCTGAGGCACTCTTCCA; Rev CGGATGTCCAC 
GTCACACTTC
• IL8: For GAGTGGACCACACTGCGCCA; Rev TCCACAACCCTCT 
GCACCCAGT
• IL6: For CCAGGAGCCCAGCTATGAAC; Rev CCCAGGGAGAAG 
GCAACTG
• CXCL1: For GAAAGCTTGCCTCAATCCTG; Rev CACCAGTGAG 
CTTCCTCCTC
• IKKA: For AATGTGTTTTTCCCCCATGA; Rev AGGCAAATGTGT 
CGTGATGA
• IKKB: For AACCAGCATCCAGATTGACC; Rev CTCAGGTCGTCC 
AGCGTTC
• IKKE: For CTGTTCTGTGGCTGCCTGTA; Rev GAGAAGCAGGT 
CCTTTCGTG
• CDKN2A: For CGGTCGGAGGCCGATCCAG; Rev GCGCCGTGG 
AGCAGCAGCAGCT
• CDKN1A: For CCTGTCACTGTCTTGTACCCT; Rev GCGTTTGGA 
GTGGTAGAAATC
• TP53: For CCGCAGTCAGATCCTAGCG; Rev AATCATCCATT 
GCTTGGGACG
• RELA: For TTCCCGATCTGAGTCCAGGT; Rev GCTTGTCTCGGG 
TTTCTGGA
The relative expression was calculated using the ΔΔCt methods 
employing	the	Ct	values	generated	with	the	7500software	version	
2.0.6 (Applied Biosystems). The data were normalized to the house-
keeping gene, RPS14 or ACTB whenever specified.
4.11  |  Nanoparticle tracking analysis
The NanoSight LM10 (Malvern Instruments) was calibrated using 
Silica Microspheres beads (Polyscience). sEV were diluted in PBS 
(Sigma- Aldrich) in order to obtain a particle number between 108–	
109 particles. Three measurements of 60 s were taken per each 
sample and the mean value was used to determine particle number. 
The movement of each particle in the field of view was measured to 
generate the average displacement of each particle per unit time, 
which was calculated using the Nanoparticle Tracking Analysis (NTA) 
3.0 software (Malvern Instruments).
4.12  |  SA- β- Galactosidase activity
The cells were incubated with 33 µM of the β- galactosidase substrate 
C12FDG (Fluorescein di- β-	D-	galactopyranose)	 (F2756	from	Sigma-	
Aldrich)	in	medium	supplemented	with	0.5%	(v/v)	EV-	depleted	FBS	
for 8 h at 37wC. After the incubation, the cells were washed with 
PBS and fixed with 4% (v/v) paraformaldehyde (Sigma- Aldrich) for 
15	min	at	room	temperature.
4.13  |  Immunofluorescence staining
To	determine	BrdU	incorporation,	50	µM	of	the	thymidine	analogue	
BrdU was added to the live cell cultures approximately 16 h before 
the end of the experiment. For all immunofluorescence, staining 
cells were washed with PBS and fixed in 4% (v/v) paraformaldehyde 
(Sigma-	Aldrich)	for	15	min	at	room	temperature.	After,	the	cells	were	
washed in PBS twice and permeabilized with 0.2% (v/v) Triton ×- 100 
(Sigma- Aldrich). Then, the cells were blocked with 1% (m/v) BSA 
and 0.2% (m/v) gelatin fish (All from Sigma- Aldrich). After, the cells 
were incubated with the concentration of primary antibody detailed 
below.	For	BrdU	detection,	the	cells	were	incubated	with	0.5	U/µl	
DNaseI and 3 mM MgCl2 (All from Sigma- Aldrich) overnight at 4°C. 
The next day, the preparations were washed with PBS twice and in-
cubated with DAPI and secondary antibody at a concentration of 
1:500.	Finally,	the	cells	were	washed	with	PBS	twice	and	the	IF	prep-
aration were maintained with PBS and stored at 4°C until the acqui-
sition of pictures using IN Cell 2200 automatized microscope (GE). 
Antibody concentrations used: p16INK4A	(Abcam,	ab108349;	1:500),	
BrdU	 (Abcam,	 ab6326;	 1:500),	 p65	 (Abcam,	AB_10859369;	 1:500	
and	F6,	Santa	Cruz_sc8008;	1:500),	IL-	8	(R&D,	MAB208;	1:500),	p53	
(Santa Cruz Biotech, sc- 126; 1:200).
4.14  |  High content analysis immunofluorescence
The images of immunofluorescence were acquired using the au-
tomated high throughput fluorescent microscope IN Cell Analyzer 
2000 (GE Healthcare) with a Å~20 objective. The fluorophores in 
wavelength settings were used to generate the IF images (‘DAPI’ for 
DAPI,	‘FITC’	for	AlexaFluor	488	FITC,	and	‘Cy5’	for	AlexaFluor647).	
Ten fields per well were acquired to include a minimum of 100 cells 
per sample well.
High content analysis (HCA) of the images were processed using 
the IN Cell Investigator v.2.7.3 software as described previously 
(Borghesan et al., 2019). DAPI was used as a nuclear mask and a 
top- hat method allowed the segmentation of cells. To detect cyto-
plasmic	 staining	 in	 cultured	 cells,	 a	 collar	 of	 7–	9	 nm	around	DAPI	
was applied. Nuclear staining in the reference wavelength, that is, all 
the other wavelengths apart from DAPI, was quantified as an aver-
age of pixel intensity (grey scale) within the specified nuclear area. 
The Cytoplasmic IF was quantified as a coefficient of variance of the 
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pixel intensities within the collar area in the reference wavelength. 
In samples of cultured cells, a threshold for positive cells was as-
signed above the average intensity of unstained or negative control 
samples.
4.15  |  Statistics
Results	are	 represented	as	 the	mean	±	S.E.M	except	where	speci-
fied. Statistical analysis are specified in the figure legend. Samples 
were compared to the senescent sample unless specified otherwise. 
Significances are considered as following: *p <	 0.05;	 **p < 0.01; 
***p < 0.001.
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